Sign Up to like & get recommendations! 1
Published in 2022 at "Advanced Science"
DOI: 10.1002/advs.202104495
Abstract: COVID‐19 vaccines have constituted a substantial scientific leap in countering severe acute respiratory syndrome type 2‐causing coronavirus (SARS‐CoV‐2), and worldwide implementation of vaccination programs has significantly contributed to the global pandemic effort by saving many… read more here.
Sign Up to like & get recommendations! 3
Published in 2022 at "Advanced Science"
DOI: 10.1002/advs.202270066
Abstract: Covid‐19 Variants and Prevention Preventive strategies such as vaccines, repurposed drugs and physical‐materials science based scenarios to create vectors interacting with SARS‐CoV‐2 to tackle the spread of the virus and its various mutations have been… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Brain and Behavior"
DOI: 10.1002/brb3.1901
Abstract: Anxiety and stress like mental illnesses are the common outcomes of viral epidemics and pandemics. Novel coronavirus disease 2019 (COVID‐19) outbreak caused by the severe acute respiratory syndrome coronavirus virus 2 (SARS‐CoV‐2) was first reported… read more here.
Sign Up to like & get recommendations! 0
Published in 2024 at "Diabetes/Metabolism Research and Reviews"
DOI: 10.1002/dmrr.3811
Abstract: Individuals with type 1 diabetes (T1D) do not appear to have an elevated risk of severe Coronavirus Disease 19 (COVID‐19). Pre‐existing immune reactivity to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2) in unexposed individuals may… read more here.
Sign Up to like & get recommendations! 1
Published in 2021 at "Immunity"
DOI: 10.1002/iid3.541
Abstract: Middle East Respiratory Syndrome (MERS) caused by MERS‐coronavirus (CoV) is a lower respiratory tract disease characterized by a high mortality rate. MERS‐CoV spread from Saudi Arabia to other countries, including South Korea. Dysfunction of the… read more here.
Sign Up to like & get recommendations! 0
Published in 2022 at "Journal of Clinical Laboratory Analysis"
DOI: 10.1002/jcla.24374
Abstract: The prompt detection of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is important in the therapeutic management of infected patients. Rapid diagnostic tests are widely used for this purpose. This study aimed to evaluate the… read more here.
Sign Up to like & get recommendations! 0
Published in 2022 at "Journal of Clinical Laboratory Analysis"
DOI: 10.1002/jcla.24545
Abstract: Coronavirus disease (COVID‐19) caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has become a global pandemic even after vaccination. We aimed to identify immunological heterogeneity over time in vaccinated healthcare workers using neutralization antibodies… read more here.
Sign Up to like & get recommendations! 0
Published in 2022 at "Journal of Heterocyclic Chemistry"
DOI: 10.1002/jhet.4541
Abstract: Abstract The novel severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) caused the ongoing pandemic named COVID‐19 which causes a serious emergency on public health hazards of international concern. In the face of a critical medical… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Journal of Medical Virology"
DOI: 10.1002/jmv.25266
Abstract: The first reported case of Middle East respiratory syndrome coronavirus (MERS‐CoV) infection was identified in Saudi Arabia in September 2012, since which time there have been over 2000 laboratory‐confirmed cases, including 750 deaths in 27… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Journal of Medical Virology"
DOI: 10.1002/jmv.26075
Abstract: In January 2020, we identified two severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)‐infected patients in a familial cluster with one person coming from Wuhan, China. The complete genome sequences of two SARS‐CoV‐2 strains isolated from… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Journal of Medical Virology"
DOI: 10.1002/jmv.27730
Abstract: Broad‐spectrum antiviral agents targeting viral RNA‐dependent RNA polymerase (RdRp) are expected to be a key therapeutic strategy in the ongoing coronavirus disease 2019 (COVID‐19) pandemic and its future variants of severe acute respiratory syndrome coronavirus… read more here.